"We recognize it has been a challenging time for employees and customers and I want to thank you for standing with us while we continue to try to resolve this matter. In my experience, it's uncommon for intellectual property disputes to result in a pharmaceutical product being restricted from the market. We remain committed to finding a resolution to this legal matter, including reasonable settlement terms with Allergan's new owner, AbbVie, and Medytox." About the Commission's Orders The ITC issued two orders 1) a limited exclusion order prohibiting the importation of Jeuveau ® into the United States for a period of 21 months and 2) a cease and desist order preventing the Company from, among other things, selling, marketing, or promoting such imported Jeuveau ® in the United States for a period of 21 months. About Evolus, Inc. Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products.